## BXP: BXP, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -1.5% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($68.05)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Assessing Boston Properties (BXP) Valuation After Recent Share Price Uptick**
- Source: Simply Wall Street | 20251202T010717 | Somewhat-Bullish | Relevance: 100%
- Boston Properties (BXP) has seen a recent share price uptick, yet its stock remains below its year-start price, reflecting challenges in the commercial property sector. Despite a negative one-year return, BXP shows healthy long-term recovery with a 27% 3-year total shareholder return and is considered 9.8% undervalued by market watchers, trading at $71.97 against a $79.80 fair value. The company's strategy of capital recycling, asset sales, and redevelopment aims to unlock higher-yielding income streams and fortify margins, driving future FFO and earnings resilience, though risks from declining occupancy remain.

**2. Boston Properties (BXP) insider plans Rule 144 sale of 36,314 common shares on NYSE**
- Source: Stock Titan | 20251201T121400 | Neutral | Relevance: 100%
- An insider at Boston Properties (BXP) plans to sell 36,314 shares of common stock under Rule 144 through Charles Schwab Corporation on the NYSE. The aggregate market value of the shares is reported as $2,619,873.00, with 158,468,685 shares of common stock outstanding. The shares were acquired on November 26, 2025, through redemption transactions of units in Boston Properties Limited Partnership.

**3. Assessing Boston Properties (BXP) Valuation After Recent Share Price Uptick**
- Source: Sahm | 20251202T230728 | Somewhat-Bullish | Relevance: 100%
- Boston Properties (BXP) has seen a recent uptick in its stock price, though it remains below its year-start level, reflecting challenges in the commercial property sector. Despite this, the company shows a healthy longer-term recovery with a 3-year total shareholder return of nearly 27%. Analysts suggest BXP is undervalued with a fair value of $79.80, supported by its capital recycling strategy and expected rebound in profitability.

**4. Assessing Boston Properties (BXP) Valuation After Recent Share Price Uptick**
- Source: Simply Wall Street | 20251202T005929 | Somewhat-Bullish | Relevance: 100%
- Boston Properties (BXP) has seen a recent share price uptick, yet remains below its year-start valuation, reflecting challenges in the commercial property sector. Despite short-term struggles, BXP shows a healthy long-term recovery with a 3-year total shareholder return of nearly 27% and is considered 9.8% undervalued by market watchers, with a fair value of $79.80. The company's strategy of capital recycling, asset sales, and redevelopment aims to unlock higher-yielding income streams and fortify net margins.

**5. Is Shifting Analyst Sentiment Altering the Investment Case for Douglas Emmett (DEI)?**
- Source: Simply Wall Street | 20251201T035150 | Neutral | Relevance: 63%
- Recent analyst downgrades for Douglas Emmett (DEI) indicate growing uncertainty regarding the company's near-term prospects, driven by challenges like low office occupancy and rising interest rates. While the company forecasts revenue growth to $1.0 billion and earnings to $88.1 million by 2028, leading to a fair value estimate of $14.32, analysts are focusing on ongoing revenue stability and earnings pressure. Investors should consider these shifting sentiments alongside previous concerns about tenant retention and occupancy rates.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Barclays | $78 | $79 | -1% |
| 2025-11-25 | Wells Fargo | $74 | $77 | -4% |
| 2025-11-14 | Evercore ISI Gr | $76 | $77 | -1% |
| 2025-11-13 | Scotiabank | $81 | $77 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Barclays | main | Equal-Weight |
| 2025-11-25 | Wells Fargo | main | Overweight |
| 2025-11-14 | Evercore ISI Gr | main | In-Line |
| 2025-11-13 | Scotiabank | main | Sector Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.20M) |
| Sells | 6 ($5.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.2% (-1.4%)
- Blackrock Inc.: 11.2% (-8.7%)
- State Street Corpora: 7.1% (-1.1%)
- Cohen & Steers Inc.: 6.9% (+112.6%)
- Apg Asset Management: 4.7% (+3.2%)

### Key Risks

1. Insider selling cluster: $5.1M in recent transactions.
2. Elevated short interest (8.8%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.29 indicates undervaluation relative to growth. Forward P/E 34.8x attractive for 187% earnings growth. Analyst sentiment negative (3 target cuts vs 1 raises). Insider selling cluster ($5.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.3B |
| Beta | 1.01 |
| 52W Range | $54.22 - $79.33 |
| Short Interest | 8.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.29 |
| Forward P/E | 34.8 |
| Current P/E | 99.8 |
| YoY Growth | 187.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 2.2% to -1.5% (-3.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.5pp (needs >4.0% for momentum thesis). RSI neutral at 49. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.53% (CS: 36) | Neutral |
| RSI_14 | 49.0 | Neutral |
| MACD Histogram | 0.23 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 0.988x | Below |
| vs SMA200 | 1.027x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $71.15
- **Stop Loss:** $68.05 (4.4% risk)
- **Target:** $74.25 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 153
- **Position Value:** $10,885.95
- **Portfolio %:** 10.89%
- **Risk Dollars:** $475.00
- **Risk Per Trade:** 0.47%
- **Modifiers:** L1 95% | L2 50% | Combined 0.47x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-27 (Est: $0.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $-0.36 | -194.0% |
| 2025Q2 | $0.42 | $0.56 | +33.6% |
| 2025Q1 | $0.33 | $0.40 | +22.5% |
| 2024Q4 | $0.44 | $0.71 | +59.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*